BridgeMD
New treatment option for Peri-implant Soft Tissue Deficiency
Official title Soft Tissue Augmentation Around Dental Implants Using Connective Tissue Graft, Submerged Tenting Abutment, or Sub-crestal Implant Placement
ClinicalTrials.gov ID: NCT07714265
What this study is testing
- What it's testing
- Peri-implant soft tissue thickness is an important determinant of the long-term stability and success of dental implants. Patients with a thin peri-implant soft tissue phenotype are at increased risk of soft tissue recession, marginal bone loss, and compromised esthetic and functional outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Adults aged 20 years or older.
- Partially edentulous patients requiring a single dental implant in the posterior mandible.
- Thin peri-implant soft tissue phenotype (\<2 mm).
- Horizontal alveolar ridge width of at least 6 mm.
- Vertical bone height of at least 10-12 mm, confirmed radiographically.
You likely can't join if
- Local pathological lesions affecting the surgical site.
- Smoking.
- Pregnancy or breastfeeding.
- Alcohol abuse or parafunctional habits that may compromise implant survival or wound healing.
- Medical or local conditions that could interfere with osseointegration, soft tissue healing, or study participation
See the full eligibility criteria
- Adults aged 20 years or older.
- Partially edentulous patients requiring a single dental implant in the posterior mandible.
- Thin peri-implant soft tissue phenotype (\<2 mm).
- Horizontal alveolar ridge width of at least 6 mm.
- Vertical bone height of at least 10-12 mm, confirmed radiographically.
- Adequate interarch restorative space for implant-supported restoration.
- Medically healthy (American Society of Anesthesiologists [ASA] Physical Status I or II).
- Good oral hygiene.
- Able and willing to provide written informed consent.
- Local pathological lesions affecting the surgical site.
- Smoking.
- Pregnancy or breastfeeding.
- Alcohol abuse or parafunctional habits that may compromise implant survival or wound healing.
- Medical or local conditions that could interfere with osseointegration, soft tissue healing, or study participation
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.